Aberrant transcriptional networks in step-wise neurogenesis of paroxysmal kinesigenic dyskinesia-induced pluripotent stem cells

Oncotarget

Volumn 7, Issue 33, 2016, Pages 53611-53627

  Li, Chun ^a   Ma, Yu ^a   Zhang, Kunshan ^c   Gu, Junjie ^a   Tang, Fan ^a   Chen, Shengdi ^a,b   Cao, Li ^b   Li, Siguang ^c,d   Jin, Ying ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^c TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^d TONGJI UNIVERSITY   (China)

Author keywords

Induced pluripotent stem cells (iPSCs); Neural differentiation; Paroxysmal kinesigenic dyskinesia (PKD); Proline rich transmembrane protein 2 (PRRT2); Transcriptome analysis

Indexed keywords

MEMBRANE PROTEIN; PROTEIN PRRT2; SMAD PROTEIN; TRANSCRIPTOME; UNCLASSIFIED DRUG; NERVE PROTEIN; PRRT2 PROTEIN, HUMAN;

ADULT; ARTICLE; CELL FATE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBROBLAST; GENE EXPRESSION PROFILING; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; MESODERMAL CELL; MIDDLE AGED; MOLECULAR PATHOLOGY; NERVE CELL DIFFERENTIATION; PAROXYSMAL KINESIGENIC DYSKINESIA; PLURIPOTENT STEM CELL; PRRT2 GENE; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; YOUNG ADULT; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL LINE; DYSTONIA; GENE REGULATORY NETWORK; GENETICS; INDUCED PLURIPOTENT STEM CELL; METABOLISM; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

CELL DIFFERENTIATION; CELL LINE; DYSTONIA; GENE REGULATORY NETWORKS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MEMBRANE PROTEINS; NERVE TISSUE PROTEINS; NEURAL STEM CELLS; NEUROGENESIS; TRANSCRIPTOME;

EID: 84982295591     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.10680     Document Type: Article

References (68)

1. Kertesz A. Paroxysmal kinesigenic choreoathetosis. An entity within the paroxysmal choreoathetosis syndrome. Description of 10 cases, including 1 autopsied. Neurology. 1967; 17:680-690.
2. Goodenough DJ, Fariello RG, Annis BL and Chun RW. Familial and acquired paroxysmal dyskinesias. A proposed classification with delineation of clinical features. Arch Neurol. 1978; 35:827-831.
3. Demirkiran M and Jankovic J. Paroxysmal dyskinesias: clinical features and classification. Ann Neurol. 1995; 38:571-579.
4. Blakeley J and Jankovic J. Secondary paroxysmal dyskinesias. Mov Disord. 2002; 17:726-734.
5. Lotze T and Jankovic J. Paroxysmal kinesigenic dyskinesias. Semin Pediatr Neurol. 2003; 10:68-79.
6. Bruno MK, Hallett M, Gwinn-Hardy K, Sorenson B, Considine E, Tucker S, Lynch DR, Mathews KD, Swoboda KJ, Harris J, Soong B-W, Ashizawa T, Jankovic J, et al. Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia. Neurology. 2004; 63:2280-2287.
7. Tomita Ha, Nagamitsu S, Wakui K, Fukushima Y, Yamada K, Sadamatsu M, Masui A, Konishi T, Matsuishi T, Aihara M, Shimizu K, Hashimoto K, Mineta M, et al. Paroxysmal kinesigenic choreoathetosis locus maps to chromosome 16p11.2-q12.1. Am J Hum Genet. 1999; 65:1688-1697.
8. Swoboda KJ, Soong B, McKenna C, Brunt ER, Litt M, Bale JF Jr, Ashizawa T, Bennett LB, Bowcock AM, Roach ES, Gerson D, Matsuura T, Heydemann PT, et al. Paroxysmal kinesigenic dyskinesia and infantile convulsions: clinical and linkage studies. Neurology. 2000; 55:224-230.
9. Bennett LB, Roach ES and Bowcock AM. A locus for paroxysmal kinesigenic dyskinesia maps to human chromosome 16. Neurology. 2000; 54:125-130.
10. Valente EM, Spacey SD, Wali GM, Bhatia KP, Dixon PH, Wood NW and Davis MB. A second paroxysmal kinesigenic choreoathetosis locus (EKD2) mapping on 16q13-q22.1 indicates a family of genes which give rise to paroxysmal disorders on human chromosome 16. Brain. 2000; 123:2040-2045.
11. Chen WJ, Lin Y, Xiong ZQ, Wei W, Ni W, Tan GH, Guo SL, He J, Chen YF, Zhang QJ, Li HF, Lin Y, Murong SX, et al. Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia. Nat Genet. 2011; 43:1252-1255.
12. Wang JL, Cao L, Li XH, Hu ZM, Li JD, Zhang JG, Liang Y, San-A, Li N, Chen SQ, Guo JF, Jiang H, Shen L, et al. Identification of PRRT2 as the causative gene of paroxysmal kinesigenic dyskinesias. Brain. 2011; 134:3493-3501.
13. Li J, Zhu X, Wang X, Sun W, Feng B, Du T, Sun B, Niu F, Wei H, Wu X, Dong L, Li L, Cai X, et al. Targeted genomic sequencing identifies PRRT2 mutations as a cause of paroxysmal kinesigenic choreoathetosis. J Med Genet. 2012; 49:76-78.
14. Liu Q, Qi Z, Wan XH, Li JY, Shi L, Lu Q, Zhou XQ, Qiao L, Wu LW, Liu XQ, Yang W, Liu Y, Cui LY, et al. Mutations in PRRT2 result in paroxysmal dyskinesias with marked variability in clinical expression. J Med Genet. 2012; 49:79-82.
15. Heron SE, Grinton BE, Kivity S, Afawi Z, Zuberi SM, Hughes JN, Pridmore C, Hodgson BL, Iona X, Sadleir LG, Pelekanos J, Herlenius E, Goldberg-Stern H, et al. PRRT2 mutations cause benign familial infantile epilepsy and infantile convulsions with choreoathetosis syndrome. Am J Hum Genet. 2012; 90:152-160.
16. Schubert J, Paravidino R, Becker F, Berger A, Bebek N, Bianchi A, Brockmann K, Capovilla G, DallaBernardina B, Fukuyama Y, Hoffmann GF, Jurkat-Rott K, Anttonen AK, et al. PRRT2 Mutations are the major cause of benign familial infantile seizures. Hum Mutat. 2012; 33:1439-1443.
17. Lee HY, Huang Y, Bruneau N, Roll P, Roberson ED, Hermann M, Quinn E, Maas J, Edwards R, Ashizawa T, Baykan B, Bhatia K, Bressman S, et al. Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions. Cell Reports. 2012a; 1:2-12.
18. Ono S, Yoshiura K, Kinoshita A, Kikuchi T, Nakane Y, Kato N, Sadamatsu M, Konishi T, Nagamitsu S, Matsuura M, Yasuda A, Komine M, Kanai K, et al. Mutations in PRRT2 responsible for paroxysmal kinesigenic dyskinesias also cause benign familial infantile convulsions. J Hum Genet. 2012; 57:338-341.
19. Ebrahimi-Fakhari D, Saffari A, Westenberger A and Klein C. The evolving spectrum of PRRT2-associated paroxysmal diseases. Brain. 2015; 138:3476-3495.
20. Heron SE and Dibbens LM. Role of PRRT2 in common paroxysmal neurological disorders: a gene with remarkable pleiotropy. J Med Genet. 2013; 50:133-139.
21. Zhang LM, An Y, Pan G, Ding YF, Zhou YF, Yao YH, Wu BL and Zhou SZ. Reduced penetrance of PRRT2 mutation in a chinese family with infantile convulsion and choreoathetosis syndrome. J Child Neurol. 2015; 30:1263-1269.
22. Ji J, Tsuk S, Salapatek AM, Huang X, Chikvashvili D, Pasyk EA, Kang Y, Sheu L, Tsushima R, Diamant N, Trimble WS, Lotan I and Gaisano HY. The 25-kDa synaptosomeassociated protein (SNAP-25) binds and inhibits delayed rectifier potassium channels in secretory cells. J Biol Chem. 2002; 277:20195-20204.
23. Hu K, Carroll J, Fedorovich S, Rickman C, Sukhodub A and Davletov B. Vesicular restriction of synaptobrevin suggests a role for calcium in membrane fusion. Nature. 2002; 415:646-650.
24. Stelzl U, Worm U, Lalowski M, Haenig C, Brembeck FH, Goehler H, Stroedicke M, Zenkner M, Schoenherr A, Koeppen S, Timm J, Mintzlaff S, Abraham C, et al. A human protein-protein interaction network: a resource for annotating the proteome. Cell. 2005; 122:957-968.
25. Schwenk J, Harmel N, Brechet A, Zolles G, Berkefeld H, Müller CS, Bildl W, Baehrens D, Hüber B, Kulik A, Klöcker N, Schulte U and Fakler B. High-resolution proteomics unravel architecture and molecular diversity of native AMPA receptor complexes. Neuron. 2012; 74:621-633.
26. Verderio C, Pozzi D, Pravettoni E, Inverardi F, Schenk U, Coco S, Proux-Gillardeaux V, Galli T, Rossetto O, Frassoni C and Matteoli M. SNAP-25 modulation of calcium dynamics underlies differences in GABAergic and glutamatergic responsiveness to depolarization. Neuron. 2004; 41:599-610.
27. Garbelli R, Inverardi F, Medici V, Amadeo A, Verderio C, Matteoli M and Frassoni C. Heterogeneous expression of SNAP-25 in rat and human brain. J Comp Neurol. 2008; 506:373-386.
28. Mandolesi G, Vanni V, Cesa R, Grasselli G, Puglisi F, Cesare P and Strata P. Distribution of the SNAP25 and SNAP23 synaptosomal-associated protein isoforms in rat cerebellar cortex. Neuroscience. 2009; 164:1084-1096.
29. Costantin L, Bozzi Y, Richichi C, Viegi A, Antonucci F, Funicello M, Gobbi M, Mennini T, Rossetto O, Montecucco C, Maffei L, Vezzani A and Caleo M. Antiepileptic effects of botulinum neurotoxin E. J Neurosci. 2005; 25:1943-1951.
30. Li M, Niu FH, Zhu XL, Wu XP, Shen N, Peng XZ and Liu Y. PRRT2 mutant leads to dysfunction of glutamate signaling. Int J Mol Sci. 2015; 16:9134-9151.
31. Takahashi K and Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126:663-676.
32. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K and Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007; 131:861-872.
33. Stadtfeld M and Hochedlinger K. Induced pluripotency: history, mechanisms, and applications. Genes Dev. 2010; 24:2239-2263.
34. Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sadelain M and Studer L. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol. 2009; 27:275-280.
35. Zhou Y, Jiang H, Gu J, Tang Y, Shen N and Jin Y. MicroRNA-195 targets ADP-ribosylation factor-like protein 2 to induce apoptosis in human embryonic stem cell-derived neural progenitor cells. Cell Death Dis. 2013; 4:e695.
36. Ma Y, Li CL, Gu JJ, Tang F, Li C, Li P, Ping P, Yang S, Li Z and Jin Y. Aberrant gene expression profiles in pluripotent stem cells induced from fibroblasts of a Klinefelter syndrome patient. J Biol Chem. 2012; 287:38970-38979.
37. Langfelder P and Horvath S. Fast R functions for robust correlations and hierarchical clustering. J Stat Softw. 2012; 46:11.
38. Huizinga W, Poot DH, Guyader JM, Klaassen R, Coolen BF, van Kranenburg M, van Geuns RJ, Uitterdijk A, Polfliet M, Vandemeulebroucke J, Leemans A, Niessen WJ and Klein S. PCA-based groupwise image registration for quantitative MRI. Med Image Anal. 2015; 29:65-78.
39. Langfelder P and Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 2008; 9:559.
40. Fei T, Xia K, Li Z, Zhou B, Zhu S, Chen H, Zhang J, Chen Z, Xiao H, Han JD and Chen YG. Genome-wide mapping of SMAD target genes reveals the role of BMP signaling in embryonic stem cell fate determination. Genome Res. 2010; 20:36-44.
41. Bellefroid EJ, Kobbe A, Gruss P, Pieler T, Gurdon JB and Papalopulu N. Xiro3 encodes a Xenopus homolog of the Drosophila Iroquois genes and functions in neural specification. EMBO J 1998; 17:191-203.
42. Robertshaw E, Matsumoto K, Lumsden A and Kiecker C. Irx3 and Pax6 establish differential competence for Shhmediated induction of GABAergic and glutamatergic neurons of the thalamus. Proc Natl Acad Sci U S A. 2013; 110:E3919-3926.
43. Siiskonen H, Oikari S, Pasonen-Seppänen S and Rilla K. Hyaluronan synthase 1: a mysterious enzyme with unexpected functions. Front Immunol. 2015; 6:43.
44. Midgley AC, Duggal L, Jenkins R, Hascall V, Steadman R, Phillips AO and Meran S. Hyaluronan regulates bone morphogenetic protein-7-dependent prevention and reversal of myofibroblast phenotype. J Biol Chem. 2015; 290:11218-11234.
45. Viola M, Karousou E, D'Angelo ML, Caon I, De Luca G, Passi A and Vigetti D. Regulated hyaluronan synthesis by vascular cells. Int J Cell Biol. 2015; 2015:208303.
46. Triggs-Raine B and Natowicz MR. Biology of hyaluronan: Insights from genetic disorders of hyaluronan metabolism. World J Biol Chem. 2015; 6:110-120.
47. Hunt LC, Gorman C, Kintakas C, McCulloch DR, Mackie EJ and White JD. Hyaluronan synthesis and myogenesis: a requirement for hyaluronan synthesis during myogenic differentiation independent of pericellular matrix formation. J Biol Chem. 2013; 288:13006-13021.
48. Simpson RM, Hong X, Wong MM, Karamariti E, Issa Bhaloo S, Warren D, Kong W, Hu Y and Xu Q. Hyaluronan is crucial for stem cell differentiation into smooth muscle lineage. Stem Cells. 2016; e-pub ahead of print 11 February 2016; doi:10.1002/stem.2328.
49. Hu Z, Mellor J, Wu J and DeLisi C. VisANT: an online visualization and analysis tool for biological interaction data. BMC Bioinformatics. 2004; 5:17.
50. Erro R, Sheerin UM and Bhatia KP. Paroxysmal dyskinesias revisited: a review of 500 genetically proven cases and a new classification. Mov Disord. 2014; 29:1108-1116.
51. Gardiner AR, Jaffer F, Dale RC, Labrum R, Erro R, Meyer E, Xiromerisiou G, Stamelou M, Walker M, Kullmann D, Warner T, Jarman P, Hanna M, et al. The clinical and genetic heterogeneity of paroxysmal dyskinesias. Brain. 2015; 138:3567-3580.
52. Huang XJ, Wang T, Wang JL, Liu XL, Che XQ, Li J, Mao X, Zhang M, Bi GH, Wu L, Zhang Y, Wang JY, Shen JY, et al. Paroxysmal kinesigenic dyskinesia: Clinical and genetic analyses of 110 patients. Neurology. 2015; 85:1546-1553.
53. Becker F, Schubert J, Striano P, Anttonen AK, Liukkonen E, Gaily E, Gerloff C, Müller S, Heußinger N, Kellinghaus C, Robbiano A, Polvi A, Zittel S, et al. PRRT2-related disorders: further PKD and ICCA cases and review of the literature. J Neurol. 2013; 260:1234-1244.
54. Meneret A, Gaudebout C, Riant F, Vidailhet M, Deplenne C and Roze E. PRRT2 mutations and paroxysmal disorders. Eur J Neurol. 2013; 20:872-878.
55. Groffen AJ, Klapwijk T, van Rootselaar AF, Groen JL and Tijssen MA. Genetic and phenotypic heterogeneity in sporadic and familial forms of paroxysmal dyskinesia. J Neurol. 2013; 260:93-99.
56. Hedera P, Xiao J, Puschmann A, Momcilovic D, Wu SW and LeDoux MS. Novel PRRT2 mutation in an African-American family with paroxysmal kinesigenic dyskinesia. BMC Neurol. 2012; 12:93.
57. Zheng W, Zhang J, Deng X, Xiao J, Yuan L, Yang Y, Guan L, Song Z, Yang Z and Deng H. Identification of a premature termination mutation in the proline-rich transmembrane protein 2 gene in a chinese family with febrile seizures. Mol Neurobiol. 2016; 53:835-841.
58. He ZW, Qu J, Zhang Y, Mao CX, Wang ZB, Mao XY, Deng ZY, Zhou BT, Yin JY, Long HY, Xiao B, Zhang Y, Zhou HH, et al. PRRT2 mutations are related to febrile seizures in epileptic patients. Int J Mol Sci. 2014; 15:23408-23417.
59. Li C, Zhou J, Shi G, Ma Y, Yang Y, Gu J, Yu H, Jin S, Wei Z, Chen F and Jin Y. Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells. Hum Mol Genet. 2009; 18:4340-4349.
60. Li C, Yang Y, Lu X, Sun Y, Gu J, Feng Y and Jin Y. Efficient derivation of Chinese human embryonic stem cell lines from frozen embryos. In Vitro Cell Dev Biol Anim. 2010; 46:186-191.
61. Ludwig TE, Levenstein ME, Jones JM, Berggren WT, Mitchen ER, Frane JL, Crandall LJ, Daigh CA, Conard KR, Piekarczyk MS, Llanas RA and Thomson JA. Derivation of human embryonic stem cells in defined conditions. Nat Biotechnol. 2006; 24:185-187.
62. Cabili MN, Trapnell C, Goff L, Koziol M, Tazon-Vega B, Regev A and Rinn JL. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 2011; 25:1915-1927.
63. Zhao W, Langfelder P, Fuller T, Dong J, Li A and Hovarth S. Weighted gene coexpression network analysis: state of the art. J Biopharm Stat. 2010; 20:281-300.
64. Zhang B and Horvath S. A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol. 2005; 4:Article17.
65. Yip AM and Horvath S. Gene network interconnectedness and the generalized topological overlap measure. BMC Bioinformatics. 2007; 8:22.
66. Langfelder P, Zhang B and Horvath S. Defining clusters from a hierarchical cluster tree: the dynamic tree cut package for R. Bioinformatics. 2008; 24:719-720.
67. Horvath S and Dong J. Geometric interpretation of gene coexpression network analysis. PLOS Comput Biol. 2008; 4:e1000117.
68. Huang DW, Sherman BT and Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources. Nature Protoc. 2009; 4:44-57.